Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "David Windley"


6 mentions found


UNH 1M mountain UnitedHealth stock over the past month. Think Centene , Molina Healthcare , UnitedHealth and Humana , among others. Managed-care companies historically buck the broader trend of health stocks and outperform in the first year after an election, according to Raymond James. Unlike UnitedHealth, shares have fallen — down 3% — since the June debate. Raymond James sees Oscar Health , HCA Healthcare and Tenet Healthcare as beneficiaries of a victory by the left.
Persons: Raymond James, Chris Meekins, Donald Trump, Joe Biden, quieted, Biden, Meekins, Centene, Trump, Bernstein, Jefferies, David Windley, UnitedHealth, Ben Hendrix, Optum, John Ransom, Piper Sandler, Ransom, Lance Wilkes, Oscar, — Ransom, Oscar's Organizations: Affordable, Trump, UnitedHealth, Republican, Biden, GOP, Federal Trade Commission, Department of Justice, ACA, Medicare, Molina Healthcare, RBC Capital Markets, CVS Health, RBC Capital, DOJ, Humana, Healthcare, GoodRx Holdings, Democratic, Oscar Health, Tenet Healthcare, Aetna Locations: Molina, UnitedHealth, U.S, Thursday's, Florida, Texas
Investors view a golden cross chart pattern as a key indication that a stock could be headed for strong gains. The move refers to the point at which a stock's 50-day moving average crosses above its 200-day counterpart. CNBC Pro screened FactSet data to find stocks close to forming golden cross patterns that might suggest future gains. The stock's 50-day moving average of $501.09 is within striking distance of its 200-day moving average of $510.19, indicating a possible golden cross if the recent trend holds. Kimco Realty Kimco Realty, another REIT, also made screen of golden cross candidates.
Persons: Wall, Jefferies, David Windley, Windley, Haendel St, Juste Organizations: CNBC, UnitedHealth, Mizuho Securities, Kimco Realty, Mizuho, RPT Realty Locations: Kimco
Morgan Stanley raised its price target on Rivian to $17 from $13. Analyst Frank Lee did raise his price target to $200 from $190, although he added that "the risk-reward is less attractive now." Guggenheim hiked the price target to $735 per share from $700. He did raise his price target for the stock to $225 from $180, although this price hike still implies that Tesla stock could fall 12%. Analyst Adam Jonas raised his price target on the stock to $17 from $13.
Persons: Morgan Stanley, Jefferies, Frank Lee, Lee, Lisa Kailai Han, Michael Morris, Morris, Guggenheim, — Jesse Pound, Morgan Stanley's Simeon Gutman, Gutman, Seth Sigman, Truist, – Samantha Subin, TD Cowen downgrades Charles Schwab, Charles Schwab's, TD Cowen, Bill Katz, Charles Schwab, Katz, mgmt, — Lisa Kailai Han, Wells, Bank of America Wells, Mike Mayo, Mayo, Goliath, Dan Levy, Levy, Dennis Geiger, Geiger, Thomas Fitzgerald, Fitzgerald, David Windley, UnitedHealth's, Windley, UNH, Adam Jonas, Rivian, Jonas, Fred Imbert Organizations: CNBC, HSBC, Qualcomm, Microsoft, Netflix, Guggenheim, Barclays, ISI, Citi, Mizuho, Bank of America, of America, Tesla, UBS, Sweetgreen, sss, IK, TD Cowen downgrades, Airlines, American Airlines, Delta, Jefferies, Presidential, Chevron, Volkswagen Locations: China, Tuesday's, Mayo, U.S, Tesla's, UnitedHealth, UNH's
TipRanks leveraged its Experts Center tool to recognize the ones with a high success rate. We also analyzed each stock recommendation made by health care sector analysts in the past decade. TipRanks' algorithms calculated the statistical significance of each rating, average return and the analysts' overall success rate. The buy recommendation generated a return of 397.9% from May 12, 2020 to May 12, 2021. Boris Peaker - TD CowenBoris Peaker has the 10th spot on the list, with a success rate of 47%.
Elevance Health, the major US health insurer formerly called Anthem, said Monday that it plans to acquire Blue Cross and Blue Shield of Louisiana in a rare merger between two Blue-affiliated health insurers. It's possible that if the merger goes through, the Louisiana Blue could flip to using Elevance's PBM. While competitors like UnitedHealth, CVS, and Humana are pushing deeper into delivering primary care, Elevance has focused on owning businesses that serve people with serious and chronic illnesses. Carelon's strategy has been to sell its services to both Elevance's own health plans and other Blue-affiliated insurers. Carelon brought in almost $41 billion in revenue in 2022, and 60% of that came from Elevance's own health plans, Boudreaux said Wednesday.
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailJefferies' David Windley weighs in on why health care was today's worst performerDavid Windley, Jefferies health care analyst, joins 'Closing Bell' to discuss the health care sector as it was today's worst performer on the S&P.
Total: 6